BMS-986141

DB14942InvestigationalSmall molecule

BMS-986141 is under investigation in clinical trial NCT02985632 (A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants).

Mechanism: Pharmacologically active on Proteinase-activated receptor 4
Curator reviewed
Formula / weight: C₂₇H₂₃N₅O₅S₂ · 561.63 g/mol (avg)
Code names: BMS-986141

Resolves to

Compound

UNIIW530IRZ40GCAS1478711-48-6ChEMBLCHEMBL3716552

Structure

InChIKeyKEEBLYWBELVGPQ-UHFFFAOYSA-NSMILESCOC1=NN2C=C(N=C2S1)C1=CC2=C(O1)C=C(OC)C=C2OCC1=CSC(=N1)C1=CC=C(C=C1)C(=O)N(C)C

Targets

Q96RI0F2RL3Q96IZ0PAWR

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-986141, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account